Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Characteristics of Second-Line Drugs for MDR-TB

Fact Sheet
Characteristics of Second-Line Drugs for MDR-TB

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

Author:

Heartland National Tuberculosis Center

Audiences:

Nurses, Physicians

Topic:

MDR TB, TB Treatment

Language:

English

Country of Origin:

United States

View Webpage

Related Materials

Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy. This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.

Report

Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004. Morbidity and Mortality Weekly Report, 55(11): 301-305, March 24, 2006.

During November 2004 - November 2005, CDC and WHO surveyed an international network of TB laboratories to assess the frequency and distribution of extensively drug-resistant (XDR) TB cases. This report summarizes the results of that survey.

Report

Tuberculosis Multirresistente (MDR) [Multidrug-Resistant Tuberculosis (MDR TB)]

This fact sheet provides an overview of multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB). This fact sheet covers definitions, symptoms, treatment, transmission, and prevention.

Fact Sheet

Global resources for the prevention,
management, and elimination of TB.